ClinicalTrials.Veeva

Menu

Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.

M

Modulex

Status

Completed

Conditions

Respiratory Syncytial Virus Bronchiolitis

Treatments

Device: Optiflow Junior
Device: Continous Positive Airway Pressure

Study type

Interventional

Funder types

Other

Identifiers

NCT02618213
S-20150007

Details and patient eligibility

About

Bronchiolitis in infants and young children often requires respiraty support. In Denmark Continous Positive Airway Pressure ( CPAP) are routinely used in children with moderate-severe bronchiolitis. The aim of the study is to compare CPAP and High Flow Oxygenation Therapy (HFOT) as tools of respiratory support in infants and young children with bronchiolitis.

Infants and young children with moderate-severe bronchiolitis and are randomized to either CPAP or HFOT.

Enrollment

50 patients

Sex

All

Ages

1 day to 24 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • infants and children with moderate respiratoric syncytial virus bronchiolitis or other viral bronchiolitis and need of respiratory support. ( clinical decision)

Exclusion criteria

  • severe bronchiolitis with P C02 > 9, decreased consciusness and risk for early progression to intensive therapy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Continous Positive Airway Pressure
Active Comparator group
Description:
CPAP is administered through a binasal tube fitted with a Benveniste gas jet administered with humified airflow. Start flow is 12-14 l/min and can be changed to maximum 15 or minimum 12 l/min. Oxygen can be supplied as needed to keep SpO2 (peripheral capillary Oxygen saturation) within acceptable limits.
Treatment:
Device: Continous Positive Airway Pressure
High Flow Oxygenation Therapy
Active Comparator group
Description:
HFOT is administered by optiflow Junior ( Fisher\&Paykal Healthcare® Auckland, New Zealand) Start flow 12-14 l/min. Oxygen can be supplied as needed to keep Sp02 within acceptable limits
Treatment:
Device: Optiflow Junior

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems